Bio-Rad Laboratories, Inc. (BIO) vs Oscar Health, Inc. (OSCR)
BIO leads on 7 of 13 compared metrics.
A side-by-side comparison of Bio-Rad Laboratories, Inc. and Oscar Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 21, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BIO vs OSCR
growth of $100 · last 5yBIO -52.2%OSCR -18.4%OSCR compounded faster
BIO OSCR
BIO vs OSCR: by the numbers
- •BIO is the larger company ($7.64B vs $7.36B market cap).
- •BIO is profitable (6.52% net margin) while OSCR runs a net loss (-0.30%).
- •OSCR grew revenue faster over the past five years (73.14% vs -0.84% CAGR).
Which is better, BIO or OSCR?
Metric tally: BIO 7 · OSCR 6It depends on what you're optimizing for:
GrowthOSCR(faster 5Y revenue CAGR)
QualityBIO(higher ROIC)
Metrics side by side
Valuation
| Metric | BIO | OSCR |
|---|---|---|
| P/E ratio | 46.53 | — |
| Forward P/E | 28.34 | 21.28● |
| P/S ratio | 2.94 | 0.70● |
| P/B ratio | 1.11● | 5.63 |
| EV / EBITDA | 18.06● | 259.51 |
| FCF yield | 4.69% | 29.85%● |
Profitability
| Metric | BIO | OSCR |
|---|---|---|
| Gross margin | 51.87%● | 17.39% |
| Operating margin | 9.25%● | 0.08% |
| Net margin | 6.52%● | -0.30% |
| ROE | 2.46%● | -2.37% |
| ROIC | 2.04%● | -27.10% |
Growth (annualized)
| Metric | BIO | OSCR |
|---|---|---|
| Revenue CAGR (5Y) | -0.84% | 73.14%● |
| EPS CAGR (5Y) | -26.27% | — |
| FCF CAGR (5Y) | -7.57% | 46.32%● |
| Total return CAGR (5Y) | -14.63% | 3.55%● |
Frequently asked
- Which is better, BIO or OSCR?
- It depends on your goal. growth: OSCR (faster 5Y revenue CAGR); quality: BIO (higher ROIC). Across all compared metrics, BIO leads 7 to 6.
- Which has grown faster, BIO or OSCR?
- Over the past five years, OSCR grew revenue faster — BIO at a -0.84% CAGR versus OSCR at 73.14%.
- Is BIO or OSCR more profitable?
- BIO runs the higher net margin — BIO at 6.52% versus OSCR at -0.30%.
- Which has been the better investment, BIO or OSCR?
- Over the past 5-year, BIO delivered the higher annualized total return — BIO at 7.20% versus OSCR at 3.55%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratioOscar Health P/E ratioBio-Rad Laboratories dividend yieldOscar Health dividend yieldBio-Rad Laboratories ROEOscar Health ROEBio-Rad Laboratories operating marginOscar Health operating marginBio-Rad Laboratories revenue growthOscar Health revenue growthBio-Rad Laboratories free cash flowOscar Health free cash flow
Bio-Rad Laboratories & Oscar Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 21, 2026.